deltatrials
Completed NA INTERVENTIONAL 1-arm NCT05304897

PRP Efficacy and Safety in BPF

Efficacy and Safety of Platelet-rich Plasma on Bronchopleural Fistula

Sponsor: Guangzhou Institute of Respiratory Disease

Interventions PRP treatment
Updated 5 times since 2022 Last updated: Jun 19, 2024 Started: Apr 16, 2022 Primary completion: Jan 25, 2024 Completion: Jan 25, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Bronchopleural Fistula and is currently completed. Guangzhou Institute of Respiratory Disease leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Apr 2022 – ~May 2022 · 30 days · monthly snapshotRecruiting~May 2022 – ~May 2024 · 24 months · monthly snapshotRecruiting~May 2024 – ~Jul 2024 · 2 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. May 2024 — Jul 2024 [monthly]

    Completed NA

    Status: RecruitingCompleted

  4. May 2022 — May 2024 [monthly]

    Recruiting NA

  5. Apr 2022 — May 2022 [monthly]

    Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Guangzhou Institute of Respiratory Disease
Data source: Guangzhou Institute of Respiratory Disease

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations